Ministry of Health and Welfare Revises Regulations Following Active Administration Committee Decision

The government has established an institutional framework to ease the burden caused by high exchange rates and rising prices of raw and subsidiary materials, thereby ensuring a stable supply of medical materials.


Price Standards for Medical Materials Revised to Reflect High Exchange Rates... Average Reimbursement Price Increased by 2% View original image

The Ministry of Health and Welfare announced on June 30 that it has revised the "Standards for Determination and Adjustment of Fees and Medical Materials," which now allows the maximum reimbursement price for medical materials under the National Health Insurance to be flexibly adjusted in line with exchange rate fluctuations. The revised rules will take effect from July 1.


This revision officially provides the legal basis for the temporary improvement of the exchange rate standard decided by the Active Administration Committee on April 27. At that time, the committee decided to uniformly raise the average reimbursement price for separately assessed medical materials by 2%, setting a maximum price independently of medical service fees in consideration of rapidly changing international circumstances and high exchange rates.


With this revision, the reference grade (Grade 0) for adjusting the maximum price of medical materials has been raised from an "exchange rate range of KRW 1,100 or more to less than KRW 1,200" to "KRW 1,300 or more to less than KRW 1,400." Accordingly, the new average reimbursement price, reflecting a 2% increase, will be applied to both existing and new products.


The Ministry of Health and Welfare has also clarified the procedures for changing the reference grade and changed the adjustment cycle for the maximum price from twice a year in April and October to January and July.


In addition, the government has established a new provision allowing for flexible adjustment of exchange rate grades and adjustment rates, subject to review by the Health Insurance Policy Deliberation Committee, to respond swiftly to sudden changes in exchange rates or international raw material prices. This enables rapid responses, such as the active administrative measure taken in April.


Even after this revision, the exchange rate standard that has been applied since April will remain unchanged.



Kwon Byungki, Director of the Health Insurance Policy Bureau at the Ministry of Health and Welfare, stated, "By establishing an institutional framework that allows us to proactively respond to exchange rate fluctuations, we hope this will serve as an opportunity to ensure both the business stability of manufacturers and importers of medical materials and the protection of the public's right to health."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing